Faked Pills: Britain Bracing for Flood of Counterfeit Weight-Loss Treatments
As the UK prepares to launch a new wave of tablet-based weight-loss treatments, experts are sounding the alarm about the risks of counterfeit pills flooding the market. With the introduction of oral versions of popular medications like Wegovy and Mounjaro, pharmaceutical companies are anticipating a surge in demand - but so too are scammers eager to cash in on unsuspecting consumers.
Pills are an easier target for fraudsters than injectables, requiring minimal equipment to manufacture and provide a wider scope for production. According to Bhavik Patel, a professor of clinical and bioanalytical chemistry at the University of Brighton, counterfeit pills can be produced with relative ease, posing a significant threat to public health.
The demand for weight-loss jabs has been on the rise, with trials suggesting that medications like Wegovy and Mounjaro can lead to an average weight loss of 14% and 20%, respectively. However, these injectables come with a hefty price tag, require an injection pen and needles, and must be refrigerated - making them inaccessible to many.
To address this shortage, pharmaceutical companies are now developing oral versions of their medications, creating tablets containing drugs that mimic the hormone GLP-1. While this development may improve access for some, it also creates a new window of opportunity for scammers to falsify pills and sell them on the black market.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has warned repeatedly about the dangers of counterfeit medications, particularly those sold online without a prescription. The agency has already seized millions worth of counterfeit weight-loss jabs in recent years, but experts say that stronger regulation and enforcement are needed to keep up with the growing demand.
One recent example of this is the MHRA's raid on a factory in Northampton, which netted over ยฃ250,000 worth of counterfeit weight-loss jabs. However, despite this significant haul, no arrests or prosecutions have been made - sparking concerns that the UK's regulatory system is not doing enough to combat counterfeiting.
Oksana Pyzik, an associate professor at the UCL school of pharmacy, warns that fake pills can be produced with varying degrees of quality and purity. "While oral weight-loss drugs may improve access, it will also widen opportunity for criminals to falsify GLP-1s," she said. "Patients need to know that they should only access these products with a prescription, under medical supervision."
As the UK prepares to launch its new wave of tablet-based weight-loss treatments, experts are urging patients to be vigilant and only purchase medications from legitimate online pharmacies or licensed retailers. The government must also ensure that it is taking adequate measures to detect and prevent counterfeiting - including developing public health campaigns to target groups with different motivations and attitudes to risk when buying medications online.
With the stakes higher than ever, one thing is clear: the UK's struggle against counterfeit weight-loss treatments will require a coordinated effort from regulatory agencies, pharmaceutical companies, and patients themselves.
As the UK prepares to launch a new wave of tablet-based weight-loss treatments, experts are sounding the alarm about the risks of counterfeit pills flooding the market. With the introduction of oral versions of popular medications like Wegovy and Mounjaro, pharmaceutical companies are anticipating a surge in demand - but so too are scammers eager to cash in on unsuspecting consumers.
Pills are an easier target for fraudsters than injectables, requiring minimal equipment to manufacture and provide a wider scope for production. According to Bhavik Patel, a professor of clinical and bioanalytical chemistry at the University of Brighton, counterfeit pills can be produced with relative ease, posing a significant threat to public health.
The demand for weight-loss jabs has been on the rise, with trials suggesting that medications like Wegovy and Mounjaro can lead to an average weight loss of 14% and 20%, respectively. However, these injectables come with a hefty price tag, require an injection pen and needles, and must be refrigerated - making them inaccessible to many.
To address this shortage, pharmaceutical companies are now developing oral versions of their medications, creating tablets containing drugs that mimic the hormone GLP-1. While this development may improve access for some, it also creates a new window of opportunity for scammers to falsify pills and sell them on the black market.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has warned repeatedly about the dangers of counterfeit medications, particularly those sold online without a prescription. The agency has already seized millions worth of counterfeit weight-loss jabs in recent years, but experts say that stronger regulation and enforcement are needed to keep up with the growing demand.
One recent example of this is the MHRA's raid on a factory in Northampton, which netted over ยฃ250,000 worth of counterfeit weight-loss jabs. However, despite this significant haul, no arrests or prosecutions have been made - sparking concerns that the UK's regulatory system is not doing enough to combat counterfeiting.
Oksana Pyzik, an associate professor at the UCL school of pharmacy, warns that fake pills can be produced with varying degrees of quality and purity. "While oral weight-loss drugs may improve access, it will also widen opportunity for criminals to falsify GLP-1s," she said. "Patients need to know that they should only access these products with a prescription, under medical supervision."
As the UK prepares to launch its new wave of tablet-based weight-loss treatments, experts are urging patients to be vigilant and only purchase medications from legitimate online pharmacies or licensed retailers. The government must also ensure that it is taking adequate measures to detect and prevent counterfeiting - including developing public health campaigns to target groups with different motivations and attitudes to risk when buying medications online.
With the stakes higher than ever, one thing is clear: the UK's struggle against counterfeit weight-loss treatments will require a coordinated effort from regulatory agencies, pharmaceutical companies, and patients themselves.